<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Neuropsychopharmacology</journal-id>
<journal-id journal-id-type="iso-abbrev">Neuropsychopharmacology</journal-id>
<journal-title-group>
<journal-title>Neuropsychopharmacology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0893-133X</issn>
<issn pub-type="epub">1740-634X</issn>
<publisher>
<publisher-name>Nature Publishing Group</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28607492</article-id>
<article-id pub-id-type="pmc">5686488</article-id>
<article-id pub-id-type="pii">npp2017123</article-id>
<article-id pub-id-type="doi">10.1038/npp.2017.123</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Cognitive Characterization of Schizophrenia Risk Variants Involved in Synaptic Transmission: Evidence of <italic>CACNA1C's</italic> Role in Working Memory</article-title>
<alt-title alt-title-type="running">SZ synaptic transmission risk variants and cognition</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Cosgrove</surname>
<given-names>Donna</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mothersill</surname>
<given-names>Omar</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kendall</surname>
<given-names>Kimberley</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Konte</surname>
<given-names>Bettina</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5287-308X</contrib-id>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Harold</surname>
<given-names>Denise</given-names>
</name>
<xref ref-type="aff" rid="aff4">4</xref>
<xref ref-type="aff" rid="aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Giegling</surname>
<given-names>Ina</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hartmann</surname>
<given-names>Annette</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Richards</surname>
<given-names>Alex</given-names>
</name>
<xref ref-type="aff" rid="aff6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mantripragada</surname>
<given-names>Kiran</given-names>
</name>
<xref ref-type="aff" rid="aff6">6</xref>
</contrib>
<contrib contrib-type="author">
<collab>The Wellcome Trust Case Control Consortium</collab>
<xref ref-type="author-notes" rid="note1">
<sup>7</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Owen</surname>
<given-names>Michael J</given-names>
</name>
<xref ref-type="aff" rid="aff6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>O’Donovan</surname>
<given-names>Michael C</given-names>
</name>
<xref ref-type="aff" rid="aff6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gill</surname>
<given-names>Michael</given-names>
</name>
<xref ref-type="aff" rid="aff4">4</xref>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0206-5337</contrib-id>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rujescu</surname>
<given-names>Dan</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Walters</surname>
<given-names>James</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Corvin</surname>
<given-names>Aiden</given-names>
</name>
<xref ref-type="aff" rid="aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Morris</surname>
<given-names>Derek W</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Donohoe</surname>
<given-names>Gary</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="corresp" rid="caf1">*</xref>
</contrib>
<aff id="aff1"><label>1</label><institution>The Cognitive Genetics &amp; Cognitive Therapy Group, The School of Psychology and Discipline of Biochemistry, The Centre for Neuroimaging &amp; Cognitive Genomics, National University of Ireland Galway</institution>, Galway, <country>Ireland</country></aff>
<aff id="aff2"><label>2</label><institution>Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University</institution>, Cardiff, <country>UK</country></aff>
<aff id="aff3"><label>3</label><institution>Department of Psychiatry, Psychotherapy and Psychosomatics, Martin-Luther-University Halle-Wittenberg</institution>, Halle, <country>Germany</country></aff>
<aff id="aff4"><label>4</label><institution>Neuropsychiatric Genetics Research Group, Department of Psychiatry, Institute of Molecular Medicine, Trinity College Dublin</institution>, Dublin, <country>Ireland</country></aff>
<aff id="aff5"><label>5</label><institution>School of Biotechnology, Dublin City University</institution>, Dublin, <country>Ireland</country></aff>
<aff id="aff6"><label>6</label><institution>MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University</institution>, Cardiff, <country>UK</country></aff>
</contrib-group>
<author-notes>
<corresp id="caf1"><label>*</label><institution>The Centre for Neuroimaging &amp; Cognitive Genomics, School of Psychology, National University of Ireland Galway</institution>, Galway, <country>Ireland</country>, Tel: +353 91 495 122, E-mail: <email>gary.donohoe@nuigalway.ie</email></corresp>
<fn fn-type="present-address" id="note1">
<label>7</label>
<p>Members of the Wellcome Trust Case Control Consortium are listed above References.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<month>12</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epreprint">
<day>13</day>
<month>06</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>23</day>
<month>08</month>
<year>2017</year>
</pub-date>
<volume>42</volume>
<issue>13</issue>
<fpage>2612</fpage>
<lpage>2622</lpage>
<history>
<date date-type="received">
<day>23</day>
<month>01</month>
<year>2017</year>
</date>
<date date-type="rev-recd">
<day>13</day>
<month>04</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>19</day>
<month>05</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2017 American College of Neuropsychopharmacology</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>American College of Neuropsychopharmacology</copyright-holder>
</permissions>
<abstract>
<p>With &gt;100 common variants associated with schizophrenia risk, establishing their biological significance is a priority. We sought to establish cognitive effects of risk variants at loci implicated in synaptic transmission by (1) identifying GWAS schizophrenia variants whose associated gene function is related to synaptic transmission, and (2) testing for association between these and measures of neurocognitive function. We selected variants, reported in the largest GWAS to date, associated with genes involved in synaptic transmission. Associations between genotype and cognitive test score were analyzed in a discovery sample (988 Irish participants, including 798 with psychosis), and replication samples (528 UK patients with schizophrenia/schizoaffective disorder; 921 German participants including 362 patients with schizophrenia). Three loci showed significant associations with neuropsychological performance in the discovery samples. This included an association between the rs2007044 (risk allele G) within <italic>CACNA1C</italic> and poorer working memory performance (increased errors B (95% CI)=0.635–4.535, <italic>p</italic>=0.012), an effect driven mainly by the psychosis groups. In an fMRI analysis of working memory performance (<italic>n</italic>=84 healthy participants, a subset of the discovery sample), we further found evidence that the same <italic>CACNA1C</italic> allele was associated with decreased functional connectivity between the right dorsolateral prefrontal cortex and right superior occipital gyrus/cuneus and anterior cingulate cortex. In conclusion, these data provide evidence to suggest that the <italic>CACNA1C</italic> risk variant rs2007044 is associated with poorer memory function that may result from risk carriers’ difficulty with top-down initiated responses caused by dysconnectivity between the right DLPFC and several cortical regions.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>